BIO-TECHNE CORPORATION
NASDAQ: TECH
▼
340.34
-12.10
-3.43%
- Key statistics
- Growth
- Profitability
- Price ratios
Highlights
Analyst Recommendation: Buy
-
Revenue
-
738.69M
-
Net Income
-
229.07M
-
Market Cap.
-
13.61B
-
Enterprise Value
-
13.64B
-
Net Profit Margin %
-
31.04
-
PEG (Price/Earnings Growth) Ratio
-
4.05
-
Beta
-
1.11
-
Forward P/E
-
61.30
-
Price/Sales
-
0.00
-
Price/Book Value
-
9.81
-
Price/Cash flow
-
43.61
-
EBITDA
-
233.50M
-
Return on Capital %
-
12.48
-
Return on Equity %
-
18.99
-
Return on Assets %
-
12.48
-
Book Value/Share
-
37.29
-
Shares Outstanding
-
38.61M
-
Last Split Factor (Date)
-
2:1 (12/4/2000)
-
Last Dividend (Ex-Date)
-
0.32 (8/17/2020)
-
Dividend Declaration Date
-
8/4/2020
Analyst Recommendation
1/26/2021
-
1 Year Price Target
-
320.00
-
Analysts
-
9
-
EPS Estimate
-
5.70
-
Cashflow Estimate
-
-
Consensus estimate data
- Financial health
- Trading statistics
- Management effectiveness
-
Financial Ratios
-
Company
-
Industry
-
Debt/Equity Ratio
-
0.22
-
0.46
-
Current Ratio
-
5.14
-
3.36
-
Quick Ratio
-
3.92
-
2.99
-
Leverage Ratio
-
1.43
-
2.02
-
Book Value/Share
-
37.29
-
1.49